RXRX

RECURSION PHARMACEUTICALS INC

Healthcare | Small Cap

-$0.26

EPS Forecast

$20.57

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.26

Revenue Forecast:

$20.57

EPS Surprise Forecast:

$0.009

Revenue Surprise Forecast:

-$0

Post-release price volatility - Very high

Post-release Overnight Move:

±10.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

58%

Probability of beating revenue consensus:

51%

Probability of beating both EPS & revs consensus:

36%

Probability of missing both EPS & revs consensus:

27%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.12

Revenue standard deviation:

$20

As % of share price:

3.67% EXTREME UNCERTAINTY

As % of market cap:

1.13% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.10

Revenue 95th %ile:

$46

EPS 75th %ile:

-$0.22

Revenue 75th %ile:

$27

EPS 25th %ile:

-$0.29

Revenue 25th %ile:

$15

EPS 5th %ile:

-$0.40

Revenue 5th %ile:

-$1

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

39% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$11

Bid-ask per Share:

$0.01